Our analysis showed that RRM2 was not only significantly upregulated in NSCLC patients compared with healthy controls, but also that the serum RRM2 levels in NSCLC patients were associated with distant metastasis and histological type, but not with tumor size or lymph node metastasis. This evidence concerns the gene RRM2 and neoplasm.